Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...
Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profileMean change in UAS7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback